ROYALTY STREAM PURCHASE AGREEMENTRoyalty Stream Purchase Agreement • March 20th, 2020 • Liminal BioSciences Inc. • Pharmaceutical preparations • Ontario
This Royalty Stream Purchase Agreement (the “Agreement”) is entered into and effective as of the 30th day of April 2018 (the “Effective Date”), by and between Prometic Life Sciences Inc., Prometic Pharma SMT Limited, Prometic Biosciences Inc. and each of their Affiliates that at any time holds an interest in the Patents or licenses any rights thereunder and becomes a party hereto as provided in Section 5(a), which entities shall be set forth on Schedule “C” hereto which schedule shall be updated as applicable from time to time (collectively referred to as “Prometic”), on the first hand, and Structured Alpha LP (“SALP” or “Buyer”), on the second hand.
LIMINAL BIOSCIENCES INC. WAIVER AND AMENDMENT OF REGISTRATION RIGHTSRegistration Rights • March 20th, 2020 • Liminal BioSciences Inc. • Pharmaceutical preparations
This waiver and amendment (this “Waiver and Amendment”) is entered into as of March 17, 2020, by and among Liminal BioSciences Inc. (formerly known as Prometic Life Sciences Inc.), a Canadian corporation (the “Company”) and Consonance Capital Master Account L.P. and P Consonance Opportunities Ltd. (each an “Investor” and, together, the “Investors”). This Waiver and Amendment is being delivered pursuant to Section 3.8 and Section 3.9 of that certain registration rights agreement (the “Registration Rights Agreement”), dated April 23, 2019, by and among the Company and the Investors. Capitalized terms used but not defined herein shall have the respective meanings set forth in the Registration Rights Agreement.
AMENDED AND RESTATED LICENSE AGREEMENT PPPS PROCESSLicense Agreement • March 20th, 2020 • Liminal BioSciences Inc. • Pharmaceutical preparations • Maryland
THIS AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”) is dated and entered into as of the 7th day of May, 2012 (the “Effective Date”) by and between:
ContractLiminal BioSciences Inc. • March 20th, 2020 • Pharmaceutical preparations • Quebec
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE LIMINAL BIOSCIENCES INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO LIMINAL BIOSCIENCES INC. IF PUBLICLY DISCLOSED.
MASTER ServIces AGREEMENTMaster Services Agreement • March 20th, 2020 • Liminal BioSciences Inc. • Pharmaceutical preparations
THIS MASTER SERVICES AGREEMENT is entered into as of this 15th day of May, 2015 (the “Effective Date”), by and between ProMetic Life Sciences, Inc. (“CUSTOMER”), having an address at 440 Armand-Frappier Boulevard, Suite 300, Laval, Quebec, H7V 4B4, Canada, and Cangene Corporation doing business as Emergent BioSolutions (“EMERGENT”), an Ontario corporation having an address at 155 Innovation Drive, Winnipeg, Manitoba, R3T 5Y3 Canada, with respect to the following:
